Seroatlas · Human Serome Atlas

CDRT15

CMT1A duplicated region transcript 15 protein

Also known as: CDRTF_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q96T59
Gene
CDRT15
Ensembl
ENSG00000223510
Chromosome
17
Canonical length
188 aa
Protein class
Predicted intracellular proteins
Subcellular location
Plasma membrane

OverviewNCBI Gene

No narrative summary is available for CDRT15 in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

188 residues, UniProt reviewed canonical sequence.

>Q96T59|CDRT15
     1  MFSCCFPTSR GCCFRNGGSE SLFRRCRRRL IPHPRRLSPV VIRRIQVPQD SLGQALAGQA
    61  TPEIPLGLQL HTVLVQEIQE LIEAQTLAPG PCAEVRALPA PAAEPEPAWE EAPPERALEL
   121  EGAPAKDQTN EELPEITEVP ESIKRRLGRR VPAATPAPRG NLLLQAWMRV HSWASRLFAP
   181  NVLPGTGP

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CDRT15 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Unknown
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.67
Highest tissue expression
20 nTPM

Expression across tissuesHPA

Tissue

  • testis: 20 nTPM
  • skin: 3.1 nTPM
  • lymph node: 2.5 nTPM
  • appendix: 1.1 nTPM
  • spleen: 0.8 nTPM
  • duodenum: 0.7 nTPM

Single-cell type

  • late primary spermatocytes: 113 nCPM
  • late spermatids: 77 nCPM
  • early spermatids: 47 nCPM
  • cardiomyocytes: 1.8 nCPM
  • leydig cells: 0.3 nCPM
  • peritubular myoid cells: 0.3 nCPM

Immune cell

  • T-reg: 0.3 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM

Brain region

  • cerebellum: 5.7 nTPM
  • pons: 4.1 nTPM
  • medulla oblongata: 3.9 nTPM
  • cerebral cortex: 3.8 nTPM
  • hippocampal formation: 3.4 nTPM
  • thalamus: 3.4 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.89
gnomAD pLI
0
gnomAD missense Z
-0.57
DepMap mean gene effect
-0.13
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CDRT15 as an antibody target. Whether an autoantibody or antibody against CDRT15 could matter depends on whether native CDRT15 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CDRT15 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CDRT15 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CDRT15. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...